Evidence map›Paper›PMID 28647780›Full record

ArticleEndocrine pathology2017

Analysis of Newly Identified and Rare Synonymous Genetic Variants in the RET Gene in Patients with Medullary Thyroid Carcinoma in Polish Population.

Maria Sromek, Małgorzata Czetwertyńska, Magdalena Tarasińska, Aneta Janiec-Jankowska, Renata Zub, Maria Ćwikła, Dorota Nowakowska, Magdalena Chechlińska

Open access · hybridAbstract read
In one paragraph

Article in Endocrine pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria SromekDepartment of Immunology, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland. maria.sromek@coi.pl.
Małgorzata CzetwertyńskaDepartment of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
Magdalena TarasińskaDepartment of Oncology, The Children's Memorial Health Institute, Warsaw, Poland.
Aneta Janiec-JankowskaDepartment of Diagnostic Laboratory of Genetic Predispositions, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
Renata ZubDepartment of Molecular and Translational Oncology, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
Maria ĆwikłaDepartment of Gastroenterological Oncology, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
Dorota NowakowskaGenetic Counseling Unit, Cancer Prevention Center, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
Magdalena ChechlińskaDepartment of Immunology, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.
The Maria Sklodowska-Curie National Research Institute of Oncology · PLChildren's Memorial Health Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gain-of-function germline mutations of the RET proto-oncogene are responsible for initiation of carcinogenesis within the thyroid gland and development of hereditary form of medullary thyroid carcinoma and MEN2 syndrome. Genotype-phenotype correlations are established for most RET mutations, but the importance of the synonymous changes in this gene remains debatable. We aimed to analyze RET gene variants in Polish population. Genetic testing for the RET gene variants was performed with standard methods in 585 people aged 1-85, including 448 patients with medullary thyroid carcinoma and 131 of their first- and second-degree relatives, as well as six patients suspected of MTC/MEN2. Besides the most frequent synonymous changes, p.Leu769Leu, p.Ser836Ser, and p.Ser904Ser, four rare changes-c.1827C>T (p.Cys609Cys), c.2364C>T (p.Ile788Ile), c.2418C>T (p.Tyr806Tyr), and c.2673G>A (p.Ser891Ser)-were found in the RET gene, in the Polish population. Two of the rare changes, p.Cys609Cys and p.Ile788Ile, had not been previously described. The frequency of molecular synonymous variants in the general population was evaluated by testing 400 anonymous blood samples of neonates. Our findings may contribute to a better understanding of the genetic diversity of the RET gene and the involvement of synonymous variants in this diversity.

Indexed as

AdolescentAdultAgedAged, 80 and overCarcinoma, NeuroendocrineChildChild, PreschoolDNA Mutational AnalysisFemaleGenetic Predisposition to DiseaseGerm-Line MutationHumansInfantMaleMiddle AgedMultiple Endocrine Neoplasia Type 2aMAS1 protein, humanProto-Oncogene MasProto-Oncogene Proteins c-retRET protein, humanMedullary thyroid carcinomaMEN2RET geneSynonymous mutationThyroid

Identifiers

PMID28647780
PMCPMC5552825
OpenAlexW2709675480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.